ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 188 filers reported holding ASCENDIS PHARMA A/S in Q1 2024. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,781,074 | -7.9% | 35,057 | +2.1% | 0.00% | – |
| Q1 2024 | $5,192,992 | +31.9% | 34,352 | +9.9% | 0.00% | – |
| Q4 2023 | $3,936,189 | +36.8% | 31,252 | +1.7% | 0.00% | – |
| Q3 2023 | $2,877,276 | +3.1% | 30,727 | -1.8% | 0.00% | – |
| Q2 2023 | $2,791,919 | -55.9% | 31,282 | -47.1% | 0.00% | – |
| Q1 2023 | $6,334,772 | -69.9% | 59,082 | -65.7% | 0.00% | -100.0% |
| Q4 2022 | $21,016,854 | +726.8% | 172,098 | +599.0% | 0.00% | – |
| Q3 2022 | $2,542,000 | +12.4% | 24,620 | +1.2% | 0.00% | – |
| Q2 2022 | $2,262,000 | -51.9% | 24,334 | -39.2% | 0.00% | – |
| Q1 2022 | $4,701,000 | +43.4% | 40,054 | +64.4% | 0.00% | – |
| Q4 2021 | $3,278,000 | -6.6% | 24,365 | +10.7% | 0.00% | – |
| Q3 2021 | $3,508,000 | +3.6% | 22,013 | -14.5% | 0.00% | – |
| Q2 2021 | $3,387,000 | +9.9% | 25,744 | +7.6% | 0.00% | – |
| Q1 2021 | $3,082,000 | -14.5% | 23,917 | +10.8% | 0.00% | – |
| Q4 2020 | $3,606,000 | +8.0% | 21,588 | -0.3% | 0.00% | – |
| Q3 2020 | $3,340,000 | +22.9% | 21,646 | +17.8% | 0.00% | – |
| Q2 2020 | $2,718,000 | +61.2% | 18,379 | +22.8% | 0.00% | – |
| Q1 2020 | $1,686,000 | -87.3% | 14,971 | -84.3% | 0.00% | -100.0% |
| Q4 2019 | $13,291,000 | +1375.1% | 95,537 | +921.6% | 0.00% | – |
| Q3 2019 | $901,000 | -13.0% | 9,352 | +3.9% | 0.00% | – |
| Q2 2019 | $1,036,000 | +13.2% | 9,000 | -34.6% | 0.00% | – |
| Q2 2018 | $915,000 | -5.0% | 13,755 | -6.6% | 0.00% | – |
| Q1 2018 | $963,000 | +30.3% | 14,723 | -20.2% | 0.00% | – |
| Q4 2017 | $739,000 | +8.8% | 18,458 | -1.6% | 0.00% | – |
| Q3 2017 | $679,000 | – | 18,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |